The Benchmark Company, LLC Announces Closing of Initial Public Offering of CNS Pharmaceuticals, Inc.
13 nov. 2019 16h30 HE
|
The Benchmark Company, Llc
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced the closing of an Initial Public Offering for CNS Pharmaceuticals, Inc. of 2,125,000 shares of common stock at...
Dawson James Securities Announces the Closing of IMAC Holdings, Inc. NASDAQ Initial Public Offering at $5.125 per Unit
15 févr. 2019 14h26 HE
|
Dawson James Securities, Inc.
BOCA RATON, Fla., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc. in conjunction with IMAC Holdings, Inc. (Nasdaq: IMAC) announced today the closing of its firm commitment...